Labshake search
Citations for R&D Systems :
401 - 450 of 10000+ citations for R 4 5 Isopropylidene 2 pentanoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... 3mg of nuclear lysates were used for IP with 2 μg IgG or 5 μg primary antibodies (normal mouse IgG, Santa Cruz Biotechnology, sc-2025; normal rabbit IgG, R&D Systems, AB-105-C ...
-
bioRxiv - Neuroscience 2021Quote: 10 ng/mL BMP-4 (R&D Systems cat. no. 314-BP)
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 404-ML, 10 ng/ml) in RPMI 1640 medium (Gibco cat ...
-
bioRxiv - Immunology 2020Quote: ... 25ng/ml IL-4 (404-ML-025, R&D Systems, Minneapolis MN) and 25ng/ml IL-21(210-21 ...
-
bioRxiv - Biochemistry 2021Quote: Four 4× stock solutions were prepared containing (i) Ube1 (R&D Systems) + UbcH5c/UBE2D3 (R&D Systems ...
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 204-IL, 35 ng/ml) in RPMI 1640 medium supplemented with 10% FBS and 2-Mercaptoethanol ...
-
bioRxiv - Cancer Biology 2023Quote: ... Th2 condition: Recombinant human IL-4 (10 ng/ml, R&D Systems), IL-5 (10 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... and stage-specific embryonic antigen-4 (SSEA4, R&D Systems, Minneapolis, USA) using immunocytochemistry (ICC) ...
-
bioRxiv - Immunology 2023Quote: ... Concentration of sCTLA-4 was estimated by ELISA (R&D Systems, DY476) or SDS-PAGE/CBB staining with bovine serum albumin (BSA ...
-
CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing LossbioRxiv - Bioengineering 2023Quote: ... specimens were stained with anti-4 hydroxynonenal (R&D Systems MSB 3249) or anti 3-nitrotyrosine ...
-
bioRxiv - Neuroscience 2023Quote: ... or anti-toll-like receptor 4 (TLR4; clone #610029, R&D Systems). All antibodies were titrated using negative control cells that don’t or poorly express the target protein ...
-
bioRxiv - Cell Biology 2022Quote: ... and Laminin (R&D Systems #3446-005-01, 4-8 µg/cm2) coated glass-bottom Petri dishes (Greiner Bio-One #627975 ...
-
bioRxiv - Immunology 2024Quote: ... 4) IL1B/IL1F2 DuoSet ELISA kits (R&D Systems, Minneapolis, MN, USA), following manufacturer’s protocols ...
-
bioRxiv - Cancer Biology 2024Quote: ... The ligands used were His-Tagged human Nectin-4 (R&D systems, catalog # 2659-N4-050 ...
-
bioRxiv - Cell Biology 2024Quote: ... 4 µl of recombinant human VEGF (1 µg/µl, R&D Systems), or 4 µl of a solution containing both FITC-traC (0.75 µg/µl ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... Cells were aspirated and incubated overnight at 4°C with either: primary goat polyclonal antibody to Human ACE-2 (AF933; R&D Systems; 1:100); primary rabbit monoclonal antibody to TMPRSS2 (ab92323 ...
-
bioRxiv - Neuroscience 2023Quote: ... for 5 min each time and subsequently incubated with blocking buffer (5% goat serum [R&D Systems, Minneapolis ...
-
bioRxiv - Developmental Biology 2021Quote: ... 2 ng/ml SCF (R&D Systems, cat. 455-MC-010), 500 ng/ml EGF (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ml GDNF (R&D Systems 212-GD-050). Cells conditioned the media for 3 days at 5% CO2 in a 37°C incubator ...
-
bioRxiv - Immunology 2021Quote: ... 10 U/mL IL-2 from R&D Systems (1150-ML), 5 U/mL IL-12 p70 from PeproTech (210-12) ...
-
bioRxiv - Bioengineering 2021Quote: ... binding to basic fibroblast growth factor (FGF-2, R&D systems) and Vascular Endothelial Growth Factor 165 (VEGF165 ...
-
bioRxiv - Microbiology 2020Quote: ... and 2 ng/ml recombinant mouse TGF-β (R&D Systems). Cells were incubated with bacterial lysates at 37°C for 72 hours ...
-
bioRxiv - Neuroscience 2022Quote: ... goat anti-Lipocalin-2 (Lcn2) (1:200, R&D systems, AF1857), goat anti-Clusterin (Clu ...
-
bioRxiv - Immunology 2022Quote: ... and Human ULBP-2 DuoSet ELISA (R&D Systems, Cat. DY1298) kits according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... and recombinant human IFNγ (2 IU/mL, R&D Systems, 285IF) for 16-20 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 2 ng/μL rhIFNγ (R&D Systems, 285-IF-100). Cell were incubated at 37 C 5% CO2 and 24 hours later ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 2% fetal bovine serum (R&D systems, Cat# S11150) and 20U/mL Penicillin-Streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2022Quote: ... Basic fibroblast growth factor (FGF-2, 20ng/ml, R&D systems) and epidermal growth factor EGF (10ng/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... sonic hedgehog C25II (days 2-7, 100ng/mL, R&D Systems). After day 13 of differentiation ...
-
bioRxiv - Cancer Biology 2022Quote: ... the Human TGF-beta 2 Quantikine ELISA Kit (R&D Systems), and the Human TGF-beta 3 DuoSet ELISA Kit (R&D Systems).
-
bioRxiv - Pharmacology and Toxicology 2021Quote: IGF-2 (catalog #792-MG, R&D Systems, Inc., Minneapolis, MN) was dissolved in 0.1% bovine serum albumin (BSA ...
-
bioRxiv - Cancer Biology 2021Quote: Human Lipocalin-2/NGAL Quantikine ELISA Kits (#DLCN20, R&D Systems) were used to measure the levels of LCN2 in the cell lines according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2020Quote: ... and recombinant human Ace-2 (R&D Systems #933-ZN-010) were diluted in OptiMEM to the desired concentrations ...
-
bioRxiv - Cell Biology 2021Quote: ... 2) TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), 3 ...
-
bioRxiv - Cell Biology 2020Quote: ... and 2 μg/mL fibronectin (1918-FN, R&D System, USA) in PBS buffer was incubated on a glass-bottom petri dish (D35-14-1.5-N ...
-
bioRxiv - Immunology 2021Quote: ... goat angiotensin converting enzyme 2 (ACE2;R&D Systems; 1:500), rabbit transmembrane serine protease 2 (TMPRSS2 ...
-
bioRxiv - Immunology 2021Quote: ... and 30 IU/ml recombinant human IL-2 (R&D Systems). Prior to transduction with VSVGwt viruses ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ml GDNF (R&D Systems 212-GD-050) for a pre-differentiation phase of two days ...
-
bioRxiv - Bioengineering 2024Quote: ... BMP-2 Quantikine ELISA Kit (biotechne®, R&D systems, UK); Alcian blue 8X ...
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human fibroblastic growth factor basic (FGF-2, R&D Systems), dimethyl sulfoxide (anhydrous ...
-
bioRxiv - Developmental Biology 2024Quote: For the goat anti-Brachyury antibody (R&D Systems, Table 2), the following protocol was employed ...
-
bioRxiv - Immunology 2024Quote: ... and 100 U/ml IL-2 (R&D Systems, Minneapolis, MN). NK-92 cells were passaged in 2–3 day interval to maintain the cell density at 2.5 × 105 – 1 × 106 cells/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... or goat anti-Lipocalin-2 (MAB1757; 1:1000; R&D systems) overnight at room temperature ...
-
bioRxiv - Immunology 2024Quote: Recombinant human IL-2 (Proleukin) was purchased from R&D Systems or obtained from the National Cancer Institute’s Biological Research Branch ...
-
bioRxiv - Cell Biology 2023Quote: ... and 20 ng/ml FGF-2 (R&D Systems, Minneapolis, MN). Media were changed daily ...
-
bioRxiv - Cancer Biology 2023Quote: ... homogenized and digested in Cell Lysis Buffer #2 (R&D Systems) containing protease inhibitors on ice for 1 hour ...
-
bioRxiv - Developmental Biology 2023Quote: ... Goat anti-Runx 2 (1:100; R&D Systems AF2006-SP) and mouse anti-GM130 (1:100 ...
-
bioRxiv - Bioengineering 2023Quote: ... BMP-2 Quantikine ELISA Kit (biotechne®, R&D systems, UK); alcian blue 8X ...
-
bioRxiv - Bioengineering 2023Quote: ... and 0.2 ng mL−1 basic FGF-2 (R&D systems). Half of the medium was changed on day 3 ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...